nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—SLC22A3—Colchicine—primary biliary cirrhosis	0.717	1	CbGbCtD
Amphetamine—Cardiomyopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00988	0.0409	CcSEcCtD
Amphetamine—Cardiomyopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00988	0.0409	CcSEcCtD
Amphetamine—Accidental injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00571	0.0237	CcSEcCtD
Amphetamine—Accidental injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00571	0.0237	CcSEcCtD
Amphetamine—Viral infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0056	0.0232	CcSEcCtD
Amphetamine—Viral infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0056	0.0232	CcSEcCtD
Amphetamine—Dysmenorrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00556	0.023	CcSEcCtD
Amphetamine—Dysmenorrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00556	0.023	CcSEcCtD
Amphetamine—SLC22A3—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00499	0.122	CbGpPWpGaD
Amphetamine—Injury—Chenodeoxycholic acid—primary biliary cirrhosis	0.00399	0.0165	CcSEcCtD
Amphetamine—Injury—Ursodeoxycholic acid—primary biliary cirrhosis	0.00399	0.0165	CcSEcCtD
Amphetamine—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00375	0.0155	CcSEcCtD
Amphetamine—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00375	0.0155	CcSEcCtD
Amphetamine—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00335	0.0139	CcSEcCtD
Amphetamine—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00335	0.0139	CcSEcCtD
Amphetamine—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.012	CcSEcCtD
Amphetamine—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.012	CcSEcCtD
Amphetamine—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00287	0.0119	CcSEcCtD
Amphetamine—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00287	0.0119	CcSEcCtD
Amphetamine—SLC22A3—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.00286	0.0699	CbGpPWpGaD
Amphetamine—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.0117	CcSEcCtD
Amphetamine—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.0117	CcSEcCtD
Amphetamine—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.00279	0.0115	CcSEcCtD
Amphetamine—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.00279	0.0115	CcSEcCtD
Amphetamine—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.0115	CcSEcCtD
Amphetamine—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.0115	CcSEcCtD
Amphetamine—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00275	0.0114	CcSEcCtD
Amphetamine—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00275	0.0114	CcSEcCtD
Amphetamine—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.00271	0.0112	CcSEcCtD
Amphetamine—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.00271	0.0112	CcSEcCtD
Amphetamine—Angioedema—Colchicine—primary biliary cirrhosis	0.00225	0.0093	CcSEcCtD
Amphetamine—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00898	CcSEcCtD
Amphetamine—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00217	0.00898	CcSEcCtD
Amphetamine—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00215	0.00889	CcSEcCtD
Amphetamine—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00215	0.00889	CcSEcCtD
Amphetamine—MAOB—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00213	0.0521	CbGpPWpGaD
Amphetamine—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00836	CcSEcCtD
Amphetamine—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00836	CcSEcCtD
Amphetamine—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00808	CcSEcCtD
Amphetamine—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00195	0.00808	CcSEcCtD
Amphetamine—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00793	CcSEcCtD
Amphetamine—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00793	CcSEcCtD
Amphetamine—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.0079	CcSEcCtD
Amphetamine—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.0079	CcSEcCtD
Amphetamine—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00779	CcSEcCtD
Amphetamine—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00779	CcSEcCtD
Amphetamine—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00762	CcSEcCtD
Amphetamine—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00184	0.00762	CcSEcCtD
Amphetamine—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00742	CcSEcCtD
Amphetamine—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00742	CcSEcCtD
Amphetamine—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00729	CcSEcCtD
Amphetamine—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00176	0.00729	CcSEcCtD
Amphetamine—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00175	0.00722	CcSEcCtD
Amphetamine—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00722	CcSEcCtD
Amphetamine—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00722	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00173	0.00717	CcSEcCtD
Amphetamine—Fatigue—Colchicine—primary biliary cirrhosis	0.00173	0.00716	CcSEcCtD
Amphetamine—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00712	CcSEcCtD
Amphetamine—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00172	0.00712	CcSEcCtD
Amphetamine—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00164	0.0068	CcSEcCtD
Amphetamine—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00675	CcSEcCtD
Amphetamine—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00163	0.00675	CcSEcCtD
Amphetamine—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00666	CcSEcCtD
Amphetamine—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00666	CcSEcCtD
Amphetamine—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.0016	0.00664	CcSEcCtD
Amphetamine—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.0016	0.00664	CcSEcCtD
Amphetamine—Urticaria—Colchicine—primary biliary cirrhosis	0.00159	0.0066	CcSEcCtD
Amphetamine—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00657	CcSEcCtD
Amphetamine—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00159	0.00657	CcSEcCtD
Amphetamine—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00159	0.00657	CcSEcCtD
Amphetamine—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00649	CcSEcCtD
Amphetamine—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00649	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00645	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00645	CcSEcCtD
Amphetamine—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00644	CcSEcCtD
Amphetamine—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00156	0.00644	CcSEcCtD
Amphetamine—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00639	CcSEcCtD
Amphetamine—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00639	CcSEcCtD
Amphetamine—CARTPT—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.00153	0.0373	CbGpPWpGaD
Amphetamine—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00148	0.00612	CcSEcCtD
Amphetamine—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00611	CcSEcCtD
Amphetamine—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00611	CcSEcCtD
Amphetamine—Asthenia—Colchicine—primary biliary cirrhosis	0.00144	0.00596	CcSEcCtD
Amphetamine—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00593	CcSEcCtD
Amphetamine—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00593	CcSEcCtD
Amphetamine—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.0059	CcSEcCtD
Amphetamine—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.0059	CcSEcCtD
Amphetamine—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.0059	CcSEcCtD
Amphetamine—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.0059	CcSEcCtD
Amphetamine—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00137	0.00569	CcSEcCtD
Amphetamine—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.0055	CcSEcCtD
Amphetamine—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.0055	CcSEcCtD
Amphetamine—CYP2D6—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.0013	0.0317	CbGpPWpGaD
Amphetamine—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00536	CcSEcCtD
Amphetamine—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00536	CcSEcCtD
Amphetamine—Vomiting—Colchicine—primary biliary cirrhosis	0.00128	0.00528	CcSEcCtD
Amphetamine—Rash—Colchicine—primary biliary cirrhosis	0.00127	0.00524	CcSEcCtD
Amphetamine—Dermatitis—Colchicine—primary biliary cirrhosis	0.00126	0.00523	CcSEcCtD
Amphetamine—Headache—Colchicine—primary biliary cirrhosis	0.00126	0.00521	CcSEcCtD
Amphetamine—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00511	CcSEcCtD
Amphetamine—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00511	CcSEcCtD
Amphetamine—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00494	CcSEcCtD
Amphetamine—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00119	0.00494	CcSEcCtD
Amphetamine—Nausea—Colchicine—primary biliary cirrhosis	0.00119	0.00494	CcSEcCtD
Amphetamine—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00475	CcSEcCtD
Amphetamine—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00475	CcSEcCtD
Amphetamine—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00471	CcSEcCtD
Amphetamine—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00471	CcSEcCtD
Amphetamine—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.0047	CcSEcCtD
Amphetamine—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.0047	CcSEcCtD
Amphetamine—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00468	CcSEcCtD
Amphetamine—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00468	CcSEcCtD
Amphetamine—CARTPT—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.00109	0.0265	CbGpPWpGaD
Amphetamine—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00444	CcSEcCtD
Amphetamine—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00444	CcSEcCtD
Amphetamine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000765	0.0187	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000722	0.0176	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000646	0.0158	CbGpPWpGaD
Amphetamine—CYP2A6—Fluoropyrimidine Activity—ABCG2—primary biliary cirrhosis	0.000635	0.0155	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000625	0.0152	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000622	0.0152	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000587	0.0143	CbGpPWpGaD
Amphetamine—SLC6A4—Monoamine Transport—AGT—primary biliary cirrhosis	0.00052	0.0127	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000492	0.012	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000486	0.0119	CbGpPWpGaD
Amphetamine—SLC6A2—Monoamine Transport—AGT—primary biliary cirrhosis	0.000447	0.0109	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000447	0.0109	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.00043	0.0105	CbGpPWpGaD
Amphetamine—CYP2A6—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000425	0.0104	CbGpPWpGaD
Amphetamine—SLC6A3—Monoamine Transport—AGT—primary biliary cirrhosis	0.000396	0.00967	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000367	0.00896	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000357	0.00871	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000353	0.00862	CbGpPWpGaD
Amphetamine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—primary biliary cirrhosis	0.000336	0.0082	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000317	0.00775	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000316	0.00772	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000307	0.00749	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000306	0.00746	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000278	0.00679	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000272	0.00664	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000264	0.00643	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000263	0.00642	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000263	0.00642	CbGpPWpGaD
Amphetamine—MAOB—Biological oxidations—GGT1—primary biliary cirrhosis	0.000255	0.00623	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000253	0.00616	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000252	0.00616	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000247	0.00603	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000233	0.00568	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.000229	0.0056	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000227	0.00555	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000227	0.00554	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000227	0.00553	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000223	0.00544	CbGpPWpGaD
Amphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	0.00022	0.00537	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000219	0.00534	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—CCL5—primary biliary cirrhosis	0.0002	0.00489	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000192	0.00468	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.00019	0.00463	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000188	0.00459	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000177	0.00432	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000176	0.00429	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—LBR—primary biliary cirrhosis	0.000176	0.00429	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.000172	0.0042	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—GGT1—primary biliary cirrhosis	0.00017	0.00414	CbGpPWpGaD
Amphetamine—TAAR1—GPCR ligand binding—AGT—primary biliary cirrhosis	0.000168	0.00409	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000157	0.00383	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000155	0.00378	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000154	0.00375	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000152	0.00372	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000151	0.00368	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000149	0.00364	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LBR—primary biliary cirrhosis	0.000149	0.00363	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000147	0.00359	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000146	0.00357	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000142	0.00346	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000137	0.00334	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000135	0.00331	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000134	0.00326	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000132	0.00322	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	0.000132	0.00321	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000131	0.00321	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—OGDH—primary biliary cirrhosis	0.000127	0.0031	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000126	0.00308	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000126	0.00307	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000125	0.00306	CbGpPWpGaD
Amphetamine—CYP2A6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000124	0.00304	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000124	0.00303	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	0.000119	0.00292	CbGpPWpGaD
Amphetamine—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000117	0.00286	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000116	0.00282	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000115	0.00281	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000115	0.0028	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	0.000113	0.00276	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PDHX—primary biliary cirrhosis	0.000113	0.00276	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000109	0.00266	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MMP3—primary biliary cirrhosis	0.000109	0.00266	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—OGDH—primary biliary cirrhosis	0.000107	0.00262	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000107	0.00262	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000107	0.00261	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—DLAT—primary biliary cirrhosis	0.000106	0.0026	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCB4—primary biliary cirrhosis	0.000106	0.0026	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000104	0.00254	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCL5—primary biliary cirrhosis	0.000103	0.00251	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000103	0.0025	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	9.83e-05	0.0024	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PDHX—primary biliary cirrhosis	9.58e-05	0.00234	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	9.54e-05	0.00233	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AGT—primary biliary cirrhosis	9.47e-05	0.00231	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	9.39e-05	0.00229	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	9.08e-05	0.00222	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—DLAT—primary biliary cirrhosis	9.01e-05	0.0022	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCB4—primary biliary cirrhosis	9.01e-05	0.0022	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	8.99e-05	0.00219	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	8.96e-05	0.00219	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	8.71e-05	0.00213	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AGT—primary biliary cirrhosis	8.6e-05	0.0021	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LBR—primary biliary cirrhosis	8.56e-05	0.00209	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	8.53e-05	0.00208	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	8.36e-05	0.00204	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	8.25e-05	0.00201	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	8.23e-05	0.00201	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	7.97e-05	0.00194	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	7.72e-05	0.00188	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	7.41e-05	0.00181	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	7.13e-05	0.00174	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.06e-05	0.00172	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	6.97e-05	0.0017	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—NOS2—primary biliary cirrhosis	6.68e-05	0.00163	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	6.48e-05	0.00158	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—AGT—primary biliary cirrhosis	6.45e-05	0.00158	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP3—primary biliary cirrhosis	6.43e-05	0.00157	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—TYK2—primary biliary cirrhosis	6.43e-05	0.00157	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	6.42e-05	0.00157	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—NUP210—primary biliary cirrhosis	6.4e-05	0.00156	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—OGDH—primary biliary cirrhosis	6.19e-05	0.00151	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	6.14e-05	0.0015	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL5—primary biliary cirrhosis	6.07e-05	0.00148	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ABCG2—primary biliary cirrhosis	5.95e-05	0.00145	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCR5—primary biliary cirrhosis	5.89e-05	0.00144	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	5.89e-05	0.00144	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	5.89e-05	0.00144	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	5.69e-05	0.00139	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PDHX—primary biliary cirrhosis	5.52e-05	0.00135	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL10—primary biliary cirrhosis	5.43e-05	0.00132	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—NUP210—primary biliary cirrhosis	5.41e-05	0.00132	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL9—primary biliary cirrhosis	5.35e-05	0.00131	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DLAT—primary biliary cirrhosis	5.19e-05	0.00127	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCB4—primary biliary cirrhosis	5.19e-05	0.00127	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	5.13e-05	0.00125	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CTGF—primary biliary cirrhosis	5.1e-05	0.00125	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.1e-05	0.00124	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AGT—primary biliary cirrhosis	5.08e-05	0.00124	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT2—primary biliary cirrhosis	5.06e-05	0.00123	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ABCG2—primary biliary cirrhosis	5.03e-05	0.00123	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.85e-05	0.00118	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	4.8e-05	0.00117	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL5—primary biliary cirrhosis	4.67e-05	0.00114	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CD80—primary biliary cirrhosis	4.5e-05	0.0011	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GOT1—primary biliary cirrhosis	4.37e-05	0.00107	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GGT1—primary biliary cirrhosis	4.37e-05	0.00107	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CTGF—primary biliary cirrhosis	4.32e-05	0.00105	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT2—primary biliary cirrhosis	4.28e-05	0.00104	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.19e-05	0.00102	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	4.18e-05	0.00102	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AGT—primary biliary cirrhosis	3.91e-05	0.000954	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARGC1A—primary biliary cirrhosis	3.88e-05	0.000948	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TYK2—primary biliary cirrhosis	3.8e-05	0.000927	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GGT1—primary biliary cirrhosis	3.69e-05	0.000901	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GOT1—primary biliary cirrhosis	3.69e-05	0.000901	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CDH5—primary biliary cirrhosis	3.61e-05	0.000882	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.48e-05	0.000849	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	3.47e-05	0.000847	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARGC1A—primary biliary cirrhosis	3.29e-05	0.000802	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	3.26e-05	0.000797	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL9—primary biliary cirrhosis	3.16e-05	0.000771	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NUP210—primary biliary cirrhosis	3.12e-05	0.000761	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	3.09e-05	0.000755	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	3.07e-05	0.000749	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AGT—primary biliary cirrhosis	3.03e-05	0.000739	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—primary biliary cirrhosis	2.99e-05	0.00073	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NFKB1—primary biliary cirrhosis	2.96e-05	0.000723	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.92e-05	0.000713	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	2.91e-05	0.00071	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	2.91e-05	0.00071	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ABCG2—primary biliary cirrhosis	2.9e-05	0.000707	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.89e-05	0.000706	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL10—primary biliary cirrhosis	2.79e-05	0.00068	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL5—primary biliary cirrhosis	2.64e-05	0.000644	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AGT—primary biliary cirrhosis	2.56e-05	0.000625	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MMP3—primary biliary cirrhosis	2.54e-05	0.00062	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CTGF—primary biliary cirrhosis	2.49e-05	0.000607	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT2—primary biliary cirrhosis	2.46e-05	0.000601	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—primary biliary cirrhosis	2.4e-05	0.000585	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—primary biliary cirrhosis	2.32e-05	0.000567	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGT—primary biliary cirrhosis	2.21e-05	0.000539	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GOT1—primary biliary cirrhosis	2.13e-05	0.000519	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GGT1—primary biliary cirrhosis	2.13e-05	0.000519	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGT—primary biliary cirrhosis	2.01e-05	0.00049	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—primary biliary cirrhosis	1.96e-05	0.000479	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.89e-05	0.000462	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1.75e-05	0.000427	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.65e-05	0.000402	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	1.62e-05	0.000397	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP3—primary biliary cirrhosis	1.5e-05	0.000366	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.5e-05	0.000366	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AGT—primary biliary cirrhosis	1.47e-05	0.00036	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—primary biliary cirrhosis	1.42e-05	0.000346	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	1.39e-05	0.00034	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	1.38e-05	0.000337	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.37e-05	0.000335	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	1.19e-05	0.000291	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	1.19e-05	0.000291	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.19e-05	0.00029	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGT—primary biliary cirrhosis	1.18e-05	0.000289	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—primary biliary cirrhosis	1.13e-05	0.000276	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.06e-05	0.000259	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CD80—primary biliary cirrhosis	1.05e-05	0.000256	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TYK2—primary biliary cirrhosis	8.86e-06	0.000216	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	8.27e-06	0.000202	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—primary biliary cirrhosis	6.98e-06	0.00017	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFKB1—primary biliary cirrhosis	6.9e-06	0.000169	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	6.34e-06	0.000155	CbGpPWpGaD
